A New Category
Biological Asset Management
Every meaningful asset class is governed by an instrument that measures it, a classification that compares it, and a cadence that updates it. Biology is the only asset that has none of those. AMSEL exists to close that gap.
Biological Asset Management (BAM) is the operating framework. The AMSEL Index is the measurement system. The clinical layer is the execution downstream. One architecture, three roles, zero overlap.
Biology is the Asset Every Other Asset Depends On
It is also the only asset class that is unmeasured, untracked, ungoverned, and uncontrolled. The category does not exist yet — it is being defined here.
Not measured
Biological capacity is observed episodically, if at all. There is no instrument that produces a continuous, governance-grade read.
Not controlled
No defined cadence, no defined output, no defined mandate. Findings sit in separate hands and never route back into a recalibrated next cycle.
Not tracked
Trajectory is the asset. Single-point readings are noise. The slope between cycles is not surfaced anywhere in the existing landscape.
Not governed
There is no asset manager for biological capital. Every other meaningful holding is governed. Biology — the asset that produces every other asset — is not.
The AMSEL System
Measurement · Scoring · Monitoring · Control
The four functions that define an asset class. Each is operated under one architecture and produces output in institutional language.
Measurement
Multi-channel signal capture under clinical control across nine systems. Standardised inputs, no estimation, no self-report.
Scoring
Cross-system integration into a single composite — the AMSEL Longevity Risk Index (ALRI). Composite (0–100). Classification (A–E).
Monitoring
Recalibration on a fixed cadence. Per-system trend vector. Stabilising · Holding · Deteriorating. The trajectory is the asset under management.
Control
Governance overlay translating the read into bands, briefings, and decision-grade output. The execution layer acts on the read — never inside the framework.
Institutional Lineage
A framework is only as defensible as the institutional source it operates on. The root system precedes the canopy.
Institutional Foundation
The System Runs On a Defined Institutional Source
The framework is not constructed from first principles. It operates on a methodology authored at BioMed Center Sonnenberg and validated against a documented reference cohort. Authority is institutional, not personal.
F-01
Methodology Source
BioMed Center Sonnenberg — the institutional source of Swiss Biological Medicine. The biological signal framework that underpins the Index.
F-02
Reference Cohort
A longitudinal documented case-base exceeding 50,000 — the empirical basis from which calibration and weighting are derived.
F-03
Clinical Authority
Dr. Thomas Rau, M.D. — pioneer of Swiss Biological Medicine. Forty years of operating practice. Direct authority over signal definition, interaction logic, and threshold calibration.
Methodology (Sonnenberg) → AMSEL Index→ ALRI → Governance
D-01 · Methodology Authority
Schwellbrunn, Switzerland
BioMed Center Sonnenberg
D-02 · Primary Operational Node
Bangkok, Thailand
AMSEL Operating Centre
D-03 · Operating Mode
Application-based access
Reviewed against framework criteria
What This is · What This is Not
A category is defined as much by what it excludes as by what it claims. The list below is the operating commitment of the framework.
This is
A measurement system for biological risk.
This is not
A clinic, a wellness brand, or a service catalogue.
This is
A governance framework with a fixed cadence.
This is not
A transactional product or annual check-up.
This is
A non-diagnostic risk read.
This is not
A diagnostic, prescriptive, or treatment offering. AMSEL does not replace the principal's primary physician, oncologist, or specialist.
This is
An institutional asset manager for biological capital.
This is not
A destination spa or premium hospitality experience. We do not compete with Clinique La Prairie, SHA, RAKxa, or Chiva-Som.
This is
A standardised methodology operated under institutional protocol — by the Sonnenberg clinical team, not a single practitioner.
This is not
A celebrity-physician offering or single-doctor practice. Methodology custodianship is institutional, not personal.
This is
A category being established — calibrated against Sonnenberg's 50,000-case foundation; AMSEL's own longitudinal cohort builds quarter on quarter.
This is not
A finished product with decades of AMSEL-specific outcome data. We do not pretend to have what we do not have.